tirzepatide from eli lilly launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can Patients Taking Experimental Obesity Drug

The medication slows gastric emptying to promote satiety, which can cause gastrointestinal symptoms including nausea, bloating, and indigestion

The typical dosing schedule of the medication is as follows: 1 mg once weekly for the first 4 weeks 2 mg once weekly for the next 4 weeks 4 mg once weekly for the next 4 weeks if tolerated by the patient 8 mg once weekly for the next 4 weeks if tolerated by the patient 12 mg once weekly if tolerated by the patient, which is the maximum dosage

PlexusDx provides personalized semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, with dose customization designed to help you find the optimal balance between therapeutic benefit and comfort

Roberge, J